Clinical Trial Update: A Phase II Study of SKB571 in Patients With Lung Cancer [Phase 2]

View source ↗

Summary

A Phase II clinical trial evaluating SKB571 in patients with non-small cell lung cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• SKB571

Snippet

Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Conditions: Lung Cancer (Non-Small Cell) | Phase 2 | Status: RECRUITING